Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce

Background Identifying subjects at risk of imminent psoriatic arthritis (PsA) would allow these subjects to participate in therapeutic interventions to delay or prevent PsA development. Methods A systematic literature review (SLR) was conducted in 2021 in Medline, Embase, PubMed, Central databases and international congress abstracts (PROSPERO CRD42022255102). All articles reporting the characteristics of patients transitioning from psoriasis (PsO) to PsA and from undifferentiated arthritis (UA) to PsA were included. Clinical and imaging characteristics were collated before PsA onset and at time of PsA diagnosis. Results Eighteen of 23 576 references evaluated for PsO/PsA transition were analysed; 14 were cohort studies, 2 case-control studies. Two SLRs were used to enrich the project but were not analysed per se. Of 7873 references focusing on UA to PsA, 3 studies were included. Meta-analysis was not possible due to excessive data heterogeneity. Patients with PsO who developed PsA often reported joint pain, joint tenderness and functional limitations. Arthralgia (PsO, n=669; incident PsA, n=99) was associated with subsequent PsA development. On imaging, subclinical enthesopathy (PsO=325; Incident PsA=39) appeared linked to later PsA development. At the time of PsA onset (incident PsA, N=214), peripheral arthritis, mainly oligo-arthritis (ie, the mean number of swollen joints ranged from 1.5 to 3.2), was the most frequent pattern of clinical presentation. Conclusions Joint pain, arthralgia and entheseal involvement detected by imaging were frequent in individuals with PsO at risk for imminent PsA. Very early PsA was mainly oligoarticular. This review informed a EULAR taskforce on transition to PsA.

[1]  D. Aletaha The undifferentiated arthritis dilemma: the story continues , 2022, Nature Reviews Rheumatology.

[2]  D. Aletaha,et al.  Intercepting psoriatic arthritis in patients with psoriasis: buy one get one free? , 2021, Annals of the Rheumatic Diseases.

[3]  A. Iagnocco,et al.  Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis , 2021, Rheumatology and Therapy.

[4]  E. Soriano,et al.  Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis , 2021, Annals of the Rheumatic Diseases.

[5]  P. Gisondi,et al.  Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis , 2021, Annals of the Rheumatic Diseases.

[6]  F. V. D. van den Hoogen,et al.  Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review , 2021, Arthritis Research & Therapy.

[7]  J. Walsh,et al.  Psoriasis Characteristics for the Early Detection of Psoriatic Arthritis , 2021, The Journal of Rheumatology.

[8]  A. Julià,et al.  Synovial Immunohistological Biomarkers of the Classification of Undifferentiated Arthritis Evolving to Rheumatoid or Psoriatic Arthritis , 2021, Frontiers in Medicine.

[9]  W. Tillett,et al.  Using Bayesian networks to identify musculoskeletal symptoms influencing the risk of developing psoriatic arthritis in people with psoriasis , 2021, Rheumatology.

[10]  A. Ogdie,et al.  Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study , 2021, Nature Reviews Rheumatology.

[11]  A. Zabotti,et al.  The transition from enthesis physiological responses in health to aberrant responses that underpin spondyloarthritis mechanisms , 2020, Current opinion in rheumatology.

[12]  A. Zabotti,et al.  From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention , 2020, Current Rheumatology Reports.

[13]  G. Schett,et al.  Structural entheseal lesions in patients with psoriasis are associated with an increased risk of progression to psoriatic arthritis. , 2020, Arthritis & Rheumatology.

[14]  V. Chandran,et al.  Declining levels of serum chemokine (C‐X‐C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker? * , 2020, The British journal of dermatology.

[15]  A. Iagnocco,et al.  Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia , 2019, RMD Open.

[16]  D. Gladman,et al.  OP0203 CHARACTERIZING THE EPIGENOMIC LANDSCAPE OF PSORIASIS PATIENTS DESTINED TO DEVELOP PSORIATIC ARTHRITIS , 2019, Oral Presentations.

[17]  J. Rasker,et al.  Subclinical synovitis and enthesitis in psoriasis patients and controls by ultrasonography in Saudi Arabia; incidence of psoriatic arthritis during two years , 2019, Clinical Rheumatology.

[18]  A. Ogdie,et al.  Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition , 2019, Nature Reviews Rheumatology.

[19]  A. Gottlieb,et al.  Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta‐analysis of observational and clinical studies , 2019, Journal of the American Academy of Dermatology.

[20]  M. Napolitano,et al.  Psoriatic arthritis onset in psoriatic patients receiving UV phototherapy in Italy. , 2018, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[21]  G. Shaddick,et al.  Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis , 2018, The British journal of dermatology.

[22]  P. Hannonen,et al.  Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study. , 2018, Clinical and experimental rheumatology.

[23]  L. Pérez,et al.  AB1147 Evolutionary study of 45 cases of undifferentiated negative hla b27 seronegative oligoarthritis , 2018 .

[24]  D. Gladman,et al.  The Development of Psoriatic Arthritis in Patients With Psoriasis Is Preceded by a Period of Nonspecific Musculoskeletal Symptoms: A Prospective Cohort Study , 2016, Arthritis & rheumatology.

[25]  D. Gladman,et al.  The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study , 2016, Arthritis & rheumatology.

[26]  A. Cavallaro,et al.  Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis , 2016, Annals of the rheumatic diseases.

[27]  P. Tak,et al.  Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials , 2012, Annals of the rheumatic diseases.

[28]  A. Ogdie,et al.  Obesity and the risk of psoriatic arthritis: a population-based study , 2012, Annals of the rheumatic diseases.

[29]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[30]  S. Gabriel,et al.  Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. , 2009, Arthritis and rheumatism.

[31]  I. Olivieri,et al.  Sensitivity of the Classification of Psoriatic Arthritis Criteria in Early Psoriatic Arthritis , 2009, The Journal of Rheumatology.

[32]  S. Lynch,et al.  Recurrence risk for psoriasis and psoriatic arthritis within sibships. , 2005, Rheumatology.

[33]  D. Gladman,et al.  Psoriatic arthritis: epidemiology, clinical features, course, and outcome , 2005, Annals of the rheumatic diseases.

[34]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .